Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 12.40
-0.90 (-6.77%)
Sep 8, 2026, 1:00 PM CST
Acepodia Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | 0.19 | 0.43 | 16.59 | - | - | |
Revenue Growth | - | -56.67% | -97.43% | - | - | - |
Cost of Revenue | - | 0.06 | 0.15 | - | - | - |
Gross Profit | - | 0.12 | 0.28 | 16.59 | - | - |
Selling, General & Admin | 165.49 | 162.57 | 145.52 | 141.63 | 175.97 | 173.84 |
Research & Development | 855.79 | 806.76 | 612.66 | 310.94 | 341.59 | 303.45 |
Operating Expenses | 1,021 | 969.32 | 758.18 | 452.57 | 517.56 | 477.29 |
Operating Income | -1,021 | -969.2 | -757.9 | -435.97 | -517.56 | -477.29 |
Interest Expense | -5.46 | -6.01 | -6.49 | -4.84 | -1.51 | -0.8 |
Interest & Investment Income | 188.44 | 207.91 | 275.26 | 132.24 | 25.55 | 0.42 |
Currency Exchange Gain (Loss) | 2.56 | -12.47 | 16.32 | -25.4 | 4.37 | -1.49 |
Other Non Operating Income (Expenses) | 4.49 | 9.39 | -0.09 | -481.23 | -925.24 | -399.36 |
EBT Excluding Unusual Items | -831.25 | -770.38 | -472.91 | -815.21 | -1,414 | -878.51 |
Gain (Loss) on Sale of Investments | -11.81 | 7.08 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | 0.03 | -0.09 | -1.51 | - | - |
Other Unusual Items | -0.01 | -0.01 | 0 | 0.17 | 0.01 | - |
Pretax Income | -843.07 | -763.29 | -472.99 | -816.54 | -1,414 | -878.51 |
Income Tax Expense | -15.02 | -8.88 | 23.76 | 0.78 | - | - |
Net Income | -828.06 | -754.4 | -496.75 | -817.32 | -1,414 | -878.51 |
Net Income to Common | -828.06 | -754.4 | -496.75 | -817.32 | -1,414 | -878.51 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 582 | 580 | 570 | 567 | 46 | 45 |
Shares Outstanding (Diluted) | 582 | 580 | 570 | 567 | 46 | 45 |
Shares Change | 1.38% | 1.66% | 0.58% | 1134.31% | 1.56% | 0.07% |
EPS (Basic) | -1.42 | -1.30 | -0.87 | -1.44 | -30.79 | -19.42 |
EPS (Diluted) | -1.42 | -1.30 | -0.87 | -1.44 | -30.79 | -19.42 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -748.36 | -778.57 | -493.91 | -462.09 | -380.49 | -386.59 |
Free Cash Flow Per Share | -1.29 | -1.34 | -0.87 | -0.81 | -8.28 | -8.55 |
Gross Margin | - | 65.41% | 65.11% | 100.00% | - | - |
Operating Margin | - | -523891.89% | -177493.91% | -2627.46% | - | - |
Profit Margin | - | -407784.32% | -116334.43% | -4925.69% | - | - |
Free Cash Flow Margin | - | -420850.81% | -115669.55% | -2784.83% | - | - |
EBITDA | -949.15 | -903.43 | -722.76 | -423.71 | -506.97 | -471.47 |
D&A For EBITDA | 72.13 | 65.77 | 35.14 | 12.27 | 10.59 | 5.82 |
EBIT | -1,021 | -969.2 | -757.9 | -435.97 | -517.56 | -477.29 |